Hanmi Science Co., Ltd.
008930 · KOSPI · Healthcare · ₩2.9T (approx. $2.2B)· Nat'l Pension stake 6.35% (2024-12-31)
₩43,100+2.1%vs prev closeclose of 2026-10-30 · not real-time
Valuation summary
Looks expensive
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics.· Source: company profile (yfinance/Yahoo Finance)
Valuation summary35/100Downside rigidity31/100Upside potential48/100
⚠ Value-trap warning
This stock is flagged by our value-trap filter (e.g. shrinking earnings, negative free cash flow, or losses). Cheap can stay cheap — read why before acting.
Which value-trap type
- Negative free cash flow — FCF yield -0.3% (the business isn't generating cash).
Score summary
A summary of valuation factors — not a buy recommendation. You decide.
Data as of: 2026-10-30 · end-of-day, not real-timeData as of — price/valuation/technicals: the close date above · NPS stake: US=quarterly SEC 13F, Korea=annual · short interest: exchange's latest settlement · fundamentals: latest filing
Peers
| Company | PER | PBR | ROE | Div | Score |
|---|---|---|---|---|---|
| 한미사이언스 | 19.2 | 2.7 | 16% | 0.7% | 35 |
| 파마리서치 | 13.0 | 3.2 | 27% | 1.7% | 66 |
| 휴젤 | 13.9 | 1.8 | 17% | 0.0% | 57 |
| 클래시스 | 12.3 | 3.1 | 26% | 3.7% | 60 |
| 씨젠 | 18.7 | 1.4 | 9% | 3.6% | 55 |
| 대웅제약 | 6.0 | 1.1 | 17% | 0.6% | 43 |
Same sector, nearest by market cap · – = no data (value traps excluded)
Chart patterns matched (observational)
Technical patterns for reference — not a buy recommendation.
Price chart
View on Naver Finance →· Chart: Naver Finance
The chart (long-term trend, Ichimoku cloud) is for observation only — not a buy or sell signal.
Structure analysis · observation only
Shows only where the current price sits within the channel structure (based on past swings).
Position: 0.0~0.5 zone · Uptrend channelStructure as of 2026-10-30
Channel levels (price by multiple)
- ×3₩111,569
- ×2.5₩99,719
- ×2₩87,870
- ×1.5₩76,021
- ×1₩64,171
- ×0.5₩52,322
- Current price₩43,100
- Baseline (0)₩40,473
The channel, levels and gaps are observational geometry showing where the current price sits within past swing structure. They are not a rebound/bottom probability, a price target, or a buy/sell signal — plain chart patterns carry no reliable predictive edge (our backtest conclusion).
A highlight of the key metrics detailed below.
PER vs its own history PER is in the top 21% of its own 8-year range (historically expensive)Range 73.1–223 · median 112.9Observational only — a lower PER can reflect slowing growth, so 'cheap' isn't always undervalued.
Why it looks cheap
- –
Why it might be risky
- P/B (Price/Book)2.7
- EV/EBITDA39.4
- P/CF (Price/Cash Flow)62.3
Strategy ranks
Top-tier in 0 of 6 evaluated strategies
Ranks within the Korea market — tap to open that ranking (ranks are per market).
Valuation
- P/E (Price/Earnings)
- 19.2
- Forward P/E
- –
- P/B (Price/Book)
- 2.7
- PEG
- –
- P/S (Price/Sales)
- 2.1
- Dividend Yield
- 0.7%
- FCF Yield
- –
- EV/EBITDA
- 39.4
- EV/Sales
- 2.1
- Net Debt / EBITDA
- 1.11
- P/CF (Price/Cash Flow)
- 62.3
Quality & growth
- ROE (Return on Equity)
- 15.5%
- ROA (Return on Assets)
- 2.9%
- Rule of 40
- 14.5
- Earnings Growth
- 51.6%
Past returns
1M
-18.4%
3M
+28.5%
6M
+10.5%
1Y
+15.1%
3Y
+28.0%
5Y
-37.1%
Past returns — they do not guarantee future results.
Enterprise value
Market cap
₩2.9T
Enterprise value (EV)
₩3.0T
Net debt
₩85.0B
vs market cap
102.9%
EV as reported by our data provider (Yahoo Finance) · net debt is our own calc (total debt − cash) · definitions differ, so EV need not equal market cap + net debt (minority interest, preferred stock)
More indicators
Sortino
0.80
Downside vol
43.50%
Max drawdown (3y)
-55.07%
Deep historical drawdown
Volatility (annual.)
66.24%
Large price swings
RSI(14) daily
41.20
RSI(14) weekly
50.00
RSI(14) monthly
53.50
vs 200d MA
8.32%
Above 200-day avg
Trend slope (annualized)
7.13%
No clear trend
FCF margin
-0.55%
Beta
0.43
Moves less than market
Payout ratio
13.47%
Sustainable
Price/Graham
1.52
Pricey vs assets/earnings
Golden cross
○ aligned
Color: green = healthy, red = caution (absolute thresholds, value/quality metrics only). Downside vol & Sortino are annualized. Max drawdown = largest drop from a 3-year peak; volatility = 1-year annualized. Price/Graham < 1 = below Graham fair value (profitable, positive-equity names only). RSI < 30 = oversold. For reference only.
Long-term trend (Ichimoku)
A Japanese trend tool. Price above the 'cloud' is supportive; below is weak. A strong uptrend doesn't mean it's cheap — stocks that have run up are usually more expensive.
D
Below the cloud (weak)
W
Above the cloud (supportive)
M
Inside the cloud (neutral)